# The Medicines (Products for Human Use-Fees) Regulations 2008, Paragraph 27: Complex Variation Applications


Where more than one Type II Complex Variation Application or Extended Type II Complex Variation Application is made at the same time by the same applicant for the variation of a marketing authorization, the fee payable under regulation 18(1)—
(a) in connection with the first application considered by the licensing authority is the appropriate amount specified in this Part of the Schedule;
(b) in connection with each of the other applications where the applications are for identical variations and in respect of which no further medical, scientific or pharmaceutical assessment is required is the amount which would be payable if the application was a Type II Application.

---
Source: https://www.legislation.gov.uk/uksi/2008/552/schedule/1/paragraph/27 (the official version)
Page: https://openlegislation.uk/medicines-products-for-human-use-fees-regulations-2008/schedule-1/paragraph-27
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.